id,investigation,disease_type,shannon
13722.58cfa82de4b0c9d6adf6a4c2,TCGA-BRCA,Breast Invasive Carcinoma,0.086264728
13722.58cfa82de4b0c9d6adf6a4ce,TCGA-BRCA,Breast Invasive Carcinoma,0.396593851
13722.58cfa82de4b0c9d6adf6a48a,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.922802124
13722.58cfa82de4b0c9d6adf6a4d4,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.78752051
13722.58cfa82de4b0c9d6adf6a529,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.248907397
13722.58cfa82de4b0c9d6adf6a46d,TCGA-BRCA,Breast Invasive Carcinoma,0.412115851
13722.58cfa82de4b0c9d6adf6a52c,TCGA-BRCA,Breast Invasive Carcinoma,1.006614485
13722.58cfa82de4b0c9d6adf6a542,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.539885868
13722.58cfa82de4b0c9d6adf6a59b,TCGA-BRCA,Breast Invasive Carcinoma,0.043196224
13722.58cfa82de4b0c9d6adf6a548,TCGA-BRCA,Breast Invasive Carcinoma,0.633056401
13722.58cfa82de4b0c9d6adf6a5a6,TCGA-SARC,Sarcoma,0.221992481
13722.58cfa82de4b0c9d6adf6a59d,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.464356659
13722.58cfa82de4b0c9d6adf6a546,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.605217676
13722.58cfa82de4b0c9d6adf6a572,TCGA-BRCA,Breast Invasive Carcinoma,0.135807954
13722.58cfa82de4b0c9d6adf6a5f2,TCGA-BRCA,Breast Invasive Carcinoma,0.055587354
13722.58cfa82de4b0c9d6adf6a656,TCGA-BRCA,Breast Invasive Carcinoma,0.140026332
13722.58cfa82de4b0c9d6adf6a610,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.17980911
13722.58cfa82de4b0c9d6adf6a624,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.523137208
13722.58cfa82de4b0c9d6adf6a60e,TCGA-BRCA,Breast Invasive Carcinoma,0.298287196
13722.58cfa82de4b0c9d6adf6a676,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.444503293
13722.58cfa82de4b0c9d6adf6a6c0,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.560646917
13722.58cfa82de4b0c9d6adf6a6d6,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.191959524
13722.58cfa82de4b0c9d6adf6a6ec,TCGA-BRCA,Breast Invasive Carcinoma,0.110060659
13722.58cfa82de4b0c9d6adf6a70c,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.497274355
13722.58cfa82de4b0c9d6adf6a6e0,TCGA-BRCA,Breast Invasive Carcinoma,1.319882761
13722.58cfa83ce4b0c9d6adf72e98,TCGA-BRCA,Breast Invasive Carcinoma,0.059682996
13722.58cfa83ce4b0c9d6adf72fd0,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.171543257
13722.58cfa83ce4b0c9d6adf72e96,TCGA-BRCA,Breast Invasive Carcinoma,0.178673779
13722.58cfa83ce4b0c9d6adf72fd8,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.285048652
13722.58cfa83ce4b0c9d6adf72ee6,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.25282743
13722.58cfa83ce4b0c9d6adf730f0,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.494062361
13722.58cfa83ce4b0c9d6adf72f94,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.164719613
13722.58cfa83ce4b0c9d6adf73120,TCGA-BRCA,Breast Invasive Carcinoma,0.206715169
13722.58cfa83ce4b0c9d6adf730e8,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.309616084
13722.58cfa83ce4b0c9d6adf72ea6,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.612893278
13722.58cfa83ce4b0c9d6adf731a2,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.171339037
13722.58cfa83ce4b0c9d6adf73074,TCGA-BRCA,Breast Invasive Carcinoma,0.543952103
13722.58cfa83ce4b0c9d6adf7310e,TCGA-BRCA,Breast Invasive Carcinoma,0.085080094
13722.58cfa82de4b0c9d6adf6a464,TCGA-SARC,Sarcoma,0.521167709
13722.58cfa82de4b0c9d6adf6a444,TCGA-BRCA,Breast Invasive Carcinoma,0.145916229
13722.58cfa82de4b0c9d6adf6a4a6,TCGA-BRCA,Breast Invasive Carcinoma,0.097879991
13722.58cfa82de4b0c9d6adf6a4a8,TCGA-BRCA,Breast Invasive Carcinoma,0.319902062
13722.58cfa82de4b0c9d6adf6a50c,TCGA-BRCA,Breast Invasive Carcinoma,0.206706899
13722.58cfa82de4b0c9d6adf6a50e,TCGA-BRCA,Breast Invasive Carcinoma,0.100857966
13722.58cfa82de4b0c9d6adf6a52e,TCGA-BRCA,Breast Invasive Carcinoma,0.092982614
13722.58cfa82de4b0c9d6adf6a526,TCGA-BRCA,Breast Invasive Carcinoma,0.351217125
13722.58cfa82de4b0c9d6adf6a53c,TCGA-BRCA,Breast Invasive Carcinoma,0.310243365
13722.58cfa82de4b0c9d6adf6a47e,TCGA-BRCA,Breast Invasive Carcinoma,0.153870198
13722.58cfa82de4b0c9d6adf6a471,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.174713313
13722.58cfa82de4b0c9d6adf6a56a,TCGA-BRCA,Breast Invasive Carcinoma,0.91697823
13722.58cfa82de4b0c9d6adf6a58a,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.135916125
13722.58cfa82de4b0c9d6adf6a591,TCGA-BRCA,Breast Invasive Carcinoma,0.171881789
13722.58cfa82de4b0c9d6adf6a5b8,TCGA-BRCA,Breast Invasive Carcinoma,0.101837901
13722.58cfa82de4b0c9d6adf6a596,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.062210423
13722.58cfa82de4b0c9d6adf6a5c6,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.07860608
13722.58cfa82de4b0c9d6adf6a614,TCGA-BRCA,Breast Invasive Carcinoma,0.092795263
13722.58cfa82de4b0c9d6adf6a63e,TCGA-BRCA,Breast Invasive Carcinoma,0.056555102
13722.58cfa82de4b0c9d6adf6a65c,TCGA-SARC,Sarcoma,0.274741466
13722.58cfa82de4b0c9d6adf6a642,TCGA-BRCA,Breast Invasive Carcinoma,0.07651916
13722.58cfa82de4b0c9d6adf6a69e,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.226701099
13722.58cfa82de4b0c9d6adf6a658,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,1.515006968
13722.58cfa82de4b0c9d6adf6a6c4,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.46427129
13722.58cfa82de4b0c9d6adf6a6bc,TCGA-BRCA,Breast Invasive Carcinoma,0.513798637
13722.58cfa82de4b0c9d6adf6a530,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.213671539
13722.58cfa82de4b0c9d6adf6a708,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.406176644
13722.58cfa82de4b0c9d6adf6a484,TCGA-SARC,Sarcoma,0.504148283
13722.58cfa83ce4b0c9d6adf72e9c,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.925235356
13722.58cfa83ce4b0c9d6adf72ea2,TCGA-BRCA,Breast Invasive Carcinoma,0.154956965
13722.58cfa83ce4b0c9d6adf72eac,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.795513028
13722.58cfa83ce4b0c9d6adf72ef8,TCGA-BRCA,Breast Invasive Carcinoma,0.093251969
13722.58cfa83ce4b0c9d6adf72f7d,TCGA-BRCA,Breast Invasive Carcinoma,0.460309676
13722.58cfa83ce4b0c9d6adf72f43,TCGA-BRCA,Breast Invasive Carcinoma,0.05458286
13722.58cfa83ce4b0c9d6adf72fae,TCGA-SARC,Sarcoma,0.193398223
13722.58cfa83ce4b0c9d6adf72fc8,TCGA-SARC,Sarcoma,0.247295429
13722.58cfa83ce4b0c9d6adf72fec,TCGA-SARC,Sarcoma,0.216987493
13722.58cfa83ce4b0c9d6adf72f9e,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.201206876
13722.58cfa83ce4b0c9d6adf72f72,TCGA-BRCA,Breast Invasive Carcinoma,0.312700799
13722.58cfa83ce4b0c9d6adf7307f,TCGA-BRCA,Breast Invasive Carcinoma,0.341986854
13722.58cfa83ce4b0c9d6adf730cb,TCGA-BRCA,Breast Invasive Carcinoma,0.093714658
13722.58cfa83ce4b0c9d6adf7309a,TCGA-BRCA,Breast Invasive Carcinoma,0.823317233
13722.58cfa83ce4b0c9d6adf73184,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.098670982
13722.58cfa83ce4b0c9d6adf73156,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.10242196
13722.58cfa83ce4b0c9d6adf730d4,TCGA-BRCA,Breast Invasive Carcinoma,0.144931118
13722.58cfa83ce4b0c9d6adf73060,TCGA-BRCA,Breast Invasive Carcinoma,0.358441574
13722.58cfa83ce4b0c9d6adf731cc,TCGA-SARC,Sarcoma,0.27637975
13722.58cfa83ce4b0c9d6adf72fea,TCGA-BRCA,Breast Invasive Carcinoma,0.601587726
13722.58cfa83ce4b0c9d6adf72f14,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.694421261
13722.58cfa82de4b0c9d6adf6a461,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.867171114
13722.58cfa82de4b0c9d6adf6a48c,TCGA-BRCA,Breast Invasive Carcinoma,0.188868391
13722.58cfa82de4b0c9d6adf6a4b4,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,1.325056967
13722.58cfa82de4b0c9d6adf6a4ea,TCGA-BRCA,Breast Invasive Carcinoma,0.050155951
13722.58cfa82de4b0c9d6adf6a510,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.224110234
13722.58cfa82de4b0c9d6adf6a64a,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.140089669
13722.58cfa82de4b0c9d6adf6a44c,TCGA-BRCA,Breast Invasive Carcinoma,0.075798969
13722.58cfa82de4b0c9d6adf6a45b,TCGA-SARC,Sarcoma,0.32204272
13722.58cfa82de4b0c9d6adf6a49a,TCGA-BRCA,Breast Invasive Carcinoma,0.531840911
13722.58cfa82de4b0c9d6adf6a522,TCGA-BRCA,Breast Invasive Carcinoma,0.2865941
13722.58cfa82de4b0c9d6adf6a53a,TCGA-SARC,Sarcoma,0.284481197
13722.58cfa82de4b0c9d6adf6a535,TCGA-BRCA,Breast Invasive Carcinoma,0.075177468
13722.58cfa82de4b0c9d6adf6a51c,TCGA-BRCA,Breast Invasive Carcinoma,0.481450925
13722.58cfa82de4b0c9d6adf6a570,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.172156072
13722.58cfa82de4b0c9d6adf6a599,TCGA-SARC,Sarcoma,0.173894695
13722.58cfa82de4b0c9d6adf6a4e2,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.948035874
13722.58cfa82de4b0c9d6adf6a5b2,TCGA-BRCA,Breast Invasive Carcinoma,0.573649121
13722.58cfa82de4b0c9d6adf6a5b3,TCGA-SARC,Sarcoma,0.428052285
13722.58cfa82de4b0c9d6adf6a5ce,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.766157698
13722.58cfa82de4b0c9d6adf6a60c,TCGA-SARC,Sarcoma,0.20232001
13722.58cfa82de4b0c9d6adf6a618,TCGA-BRCA,Breast Invasive Carcinoma,0.073039477
13722.58cfa82de4b0c9d6adf6a61e,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.090555145
13722.58cfa82de4b0c9d6adf6a640,TCGA-SARC,Sarcoma,0.150231582
13722.58cfa82de4b0c9d6adf6a65e,TCGA-SARC,Sarcoma,0.419509581
13722.58cfa82de4b0c9d6adf6a674,TCGA-SARC,Sarcoma,0.693870308
13722.58cfa82de4b0c9d6adf6a68a,TCGA-BRCA,Breast Invasive Carcinoma,0.38733492
13722.58cfa82de4b0c9d6adf6a65f,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.29484376
13722.58cfa82de4b0c9d6adf6a6d4,TCGA-SARC,Sarcoma,0.180584117
13722.58cfa830e4b0c9d6adf6bb98,TCGA-BRCA,Breast Invasive Carcinoma,0.232954235
13722.58cfa83ce4b0c9d6adf72eb0,TCGA-BRCA,Breast Invasive Carcinoma,0.070445669
13722.58cfa83ce4b0c9d6adf72edb,TCGA-BRCA,Breast Invasive Carcinoma,0.085902014
13722.58cfa83ce4b0c9d6adf72ef4,TCGA-SARC,Sarcoma,0.249751302
13722.58cfa83ce4b0c9d6adf72f45,TCGA-SARC,Sarcoma,0.247270839
13722.58cfa83ce4b0c9d6adf72f0d,TCGA-SARC,Sarcoma,0.265860045
13722.58cfa83ce4b0c9d6adf72f2c,TCGA-SARC,Sarcoma,0.124788709
13722.58cfa83ce4b0c9d6adf72f7b,TCGA-SARC,Sarcoma,0.189993206
13722.58cfa83ce4b0c9d6adf72fb2,TCGA-BRCA,Breast Invasive Carcinoma,0.125329534
13722.58cfa83ce4b0c9d6adf72f73,TCGA-BRCA,Breast Invasive Carcinoma,0.254559004
13722.58cfa83ce4b0c9d6adf73082,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.052195897
13722.58cfa83ce4b0c9d6adf7308c,TCGA-SARC,Sarcoma,0.189093381
13722.58cfa83ce4b0c9d6adf730ac,TCGA-BRCA,Breast Invasive Carcinoma,0.129819181
13722.58cfa83ce4b0c9d6adf730c0,TCGA-SARC,Sarcoma,0.260316833
13722.58cfa83ce4b0c9d6adf730e0,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.22128302
13722.58cfa83ce4b0c9d6adf730fa,TCGA-BRCA,Breast Invasive Carcinoma,0.274065397
13722.58cfa83ce4b0c9d6adf7313a,TCGA-SARC,Sarcoma,0.212113119
13722.58cfa83ce4b0c9d6adf73142,TCGA-SARC,Sarcoma,0.203038413
13722.58cfa83ce4b0c9d6adf731d0,TCGA-SARC,Sarcoma,0.379062951
13722.58cfa83ce4b0c9d6adf731b8,TCGA-SARC,Sarcoma,0.476959562
13722.58cfa82de4b0c9d6adf6a6fa,TCGA-BRCA,Breast Invasive Carcinoma,0.455898845
13722.58cfa82de4b0c9d6adf6a5ee,TCGA-BRCA,Breast Invasive Carcinoma,0.499664891
13722.58cfa82de4b0c9d6adf6a4d6,TCGA-BRCA,Breast Invasive Carcinoma,0.100612493
13722.58cfa83ce4b0c9d6adf730b4,TCGA-BRCA,Breast Invasive Carcinoma,0.507117247
13722.58cfa82de4b0c9d6adf6a534,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,0.214406389
13722.58cfa82de4b0c9d6adf6a577,TCGA-CESC,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.278645436
13722.58cfa82de4b0c9d6adf6a666,TCGA-SARC,Sarcoma,0.258703826
13722.58cfa82fe4b0c9d6adf6b8e0,TCGA-BRCA,Breast Invasive Carcinoma,0.757252821
13722.58cfa83ce4b0c9d6adf72efc,TCGA-SARC,Sarcoma,0.379172454
13722.58cfa83ce4b0c9d6adf73090,TCGA-UCEC,Uterine Corpus Endometrial Carcinoma,1.494389445